111 related articles for article (PubMed ID: 38529960)
1. Correction for Huang et al., "Chemotherapeutic Drugs Induce Different Gut Microbiota Disorder Pattern and NOD/RIP2/NF-κB Signaling Pathway Activation That Lead to Different Degrees of Intestinal Injury".
Huang B; Gui M; Ni Z; He Y; Zhao J; Peng J; Lin J
Microbiol Spectr; 2024 May; 12(5):e0011224. PubMed ID: 38529960
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic Drugs Induce Different Gut Microbiota Disorder Pattern and NOD/RIP2/NF-κB Signaling Pathway Activation That Lead to Different Degrees of Intestinal Injury.
Huang B; Gui M; Ni Z; He Y; Zhao J; Peng J; Lin J
Microbiol Spectr; 2022 Dec; 10(6):e0167722. PubMed ID: 36222691
[TBL] [Abstract][Full Text] [Related]
3. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota-Derived Diaminopimelic Acid Promotes the NOD1/RIP2 Signaling Pathway and Plays a Key Role in the Progression of Severe Acute Pancreatitis.
Jiao J; Liu J; Li Q; Zhang G; Pan C; Luo F; Zhang Q; Qi B; Zhao L; Yin P; Shang D
Front Cell Infect Microbiol; 2022; 12():838340. PubMed ID: 35811665
[TBL] [Abstract][Full Text] [Related]
5. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation.
Ruefli-Brasse AA; Lee WP; Hurst S; Dixit VM
J Biol Chem; 2004 Jan; 279(2):1570-4. PubMed ID: 14638696
[TBL] [Abstract][Full Text] [Related]
6. Gene silencing of receptor-interacting protein 2 protects against cigarette smoke-induced acute lung injury.
Dong J; Liao W; Tan LH; Yong A; Peh WY; Wong WSF
Pharmacol Res; 2019 Jan; 139():560-568. PubMed ID: 30394320
[TBL] [Abstract][Full Text] [Related]
7. Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis.
Schirbel A; Kessler S; Rieder F; West G; Rebert N; Asosingh K; McDonald C; Fiocchi C
Gastroenterology; 2013 Mar; 144(3):613-623.e9. PubMed ID: 23149220
[TBL] [Abstract][Full Text] [Related]
8. Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota-Gut-Brain Axis.
Nie H; Ge J; Yang K; Peng Z; Wu H; Yang T; Mei Z
Drug Des Devel Ther; 2023; 17():3571-3588. PubMed ID: 38058793
[TBL] [Abstract][Full Text] [Related]
9. RIP2 is required for NOD signaling but not for Th1 cell differentiation and cellular allograft rejection.
Fairhead T; Lian D; McCully ML; Garcia B; Zhong R; Madrenas J
Am J Transplant; 2008 Jun; 8(6):1143-50. PubMed ID: 18522545
[TBL] [Abstract][Full Text] [Related]
10. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
Hu YH; Jiao BH; Wang CY; Wu JL
CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245
[TBL] [Abstract][Full Text] [Related]
11. Babao Dan alleviates gut immune and microbiota disorders while impacting the TLR4/MyD88/NF-кB pathway to attenuate 5-Fluorouracil-induced intestinal injury.
Huang B; Gui M; An H; Shen J; Ye F; Ni Z; Zhan H; Che L; Lai Z; Zeng J; Peng J; Lin J
Biomed Pharmacother; 2023 Oct; 166():115387. PubMed ID: 37643486
[TBL] [Abstract][Full Text] [Related]
12. Effects of Si-Miao-Yong-An decoction on myocardial I/R rats by regulating gut microbiota to inhibit LPS-induced TLR4/NF-κB signaling pathway.
Cui Y; Zhang F; Xu W; Li Z; Zou J; Gao P; Hu J
BMC Complement Med Ther; 2023 Jun; 23(1):180. PubMed ID: 37268931
[TBL] [Abstract][Full Text] [Related]
13. ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions.
Sarkar A; Duncan M; Hart J; Hertlein E; Guttridge DC; Wewers MD
J Immunol; 2006 Apr; 176(8):4979-86. PubMed ID: 16585594
[TBL] [Abstract][Full Text] [Related]
14. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
[TBL] [Abstract][Full Text] [Related]
15. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance.
Kong L; Chen J; Ji X; Qin Q; Yang H; Liu D; Li D; Sun M
J Exp Clin Cancer Res; 2021 Jan; 40(1):18. PubMed ID: 33413501
[TBL] [Abstract][Full Text] [Related]
17. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
[TBL] [Abstract][Full Text] [Related]
18. RIP2 Is a Critical Regulator for NLRs Signaling and MHC Antigen Presentation but Not for MAPK and PI3K/Akt Pathways.
Wu XM; Chen WQ; Hu YW; Cao L; Nie P; Chang MX
Front Immunol; 2018; 9():726. PubMed ID: 29692779
[TBL] [Abstract][Full Text] [Related]
19. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
[TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharide attenuates bleomycin-induced pulmonary fibrosis by inhibiting TLR4/ NF-κB signaling pathway and regulating gut microbiota.
Wei Y; Qi M; Liu C; Li L
Eur J Pharmacol; 2023 Apr; 944():175594. PubMed ID: 36804541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
